Ads
related to: chemotherapy prostate cancer life expectancy elderly- Educational Brochures
Get Resources Now For
APC Treatment
- Safety & Efficacy Video
Watch A Video To Learn
More About This Treatment Option.
- Coverage for Rx Treatment
Learn About Coverage
In Your Area
- Patient Support Program
Support to Help Your Patients
Get Started and Stay on Track
- Find Patient Support
Discover Available Options
To Support Your Patients
- Access Patient Resources
Download Dosing Card &
Support Program Brochure
- Educational Brochures
Search results
Results From The WOW.Com Content Network
It is not clear if cryosurgery improves the quality of life and mortality from prostate cancer compared to radiation therapy. [15] Potential adverse effects associated with cryosurgery include urinary retention, incontinence, and pain in the perineal region, penis, or scrotum. [15] Impotence occurs up to ninety percent of the time.
The National Institute of Health (NIH) attributes the increase in the 5-year relative survival of prostate cancer (from 69% in the 1970s to 100% in 2006) to screening and diagnosis and due to the fact that men that participate in screening tend to be healthier and live longer than the average man and testing techniques that are able to detect ...
Prostate cancer is a major topic of ongoing research. From 2016–2020, over $1.26 billion was invested in prostate cancer research, representing around 5% of global cancer research funds. [123] This places prostate cancer 10th among 18 common cancer types in funding per cancer death, and 9th in funding per disability-adjusted life year lost. [124]
The Prostate Cancer Intervention versus Observation Trial (PIVOT) randomized 731 men diagnosed with localized prostate cancer to radical prostatectomy or observation (mean age 67 years; median PSA 7.8 ng/ml). [10] In the observation group, bone metastases and prostate cancer death occurred in 10.6% and 8.4%, respectively through 12 years. [10]
In the United States during 2013–2017, the age-adjusted mortality rate for all types of cancer was 189.5/100,000 for males, and 135.7/100,000 for females. [1] Below is an incomplete list of age-adjusted mortality rates for different types of cancer in the United States from the Surveillance, Epidemiology, and End Results program.
Five-year survival rates can be used to compare the effectiveness of treatments. Use of five-year survival statistics is more useful in aggressive diseases that have a shorter life expectancy following diagnosis, such as lung cancer, and less useful in cases with a long life expectancy, such as prostate cancer.
Ads
related to: chemotherapy prostate cancer life expectancy elderly